Skip to search formSkip to main contentSkip to account menu

NNC 711

Known as: NNC-711 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (6)

AnticonvulsantsGABA AntagonistsNeurotransmitter Uptake InhibitorsNicotinic Acids

Narrower (1)

NO 711

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
gamma-aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine.
1998
1998
Veratridine- and glutamate-induced release of [ 3 H ]-GABA from cultured chick retina cells: possible involvement of a GAT-1-like subtype of GABA transporter
1998
1998
Nitric oxide differentially affects the exocytotic and the carrier-mediated release of [3H] gamma-aminobutyric acid in rat hippocampal synaptosomes.
Highly Cited
1997
Highly Cited
1997
Antiepileptic Effects of Tiagabine, a Selective GABA Uptake Inhibitor, in the Rat Kindling Model of Temporal Lobe Epilepsy
Summary: Purpose: We determined the antiepileptic profile of tiagabine (TGB), a selective γ‐aminobutyric acid (GABA) uptake… 
Highly Cited
1995
Highly Cited
1995
Decreased GABA release following tonic-clonic seizures is associated with an increase in extracellular glutamate in rat hippocampus in vivo
1995
1995
The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy.
Highly Cited
1994
Highly Cited
1994
Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.
1993
1993
Glutamate increases the [Ca2+]i but stimulates Ca2+-independent release of [3H]GABA in cultured chick retina cells
Highly Cited
1992
Highly Cited
1992
NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization.
1992
1992
Ca2+-dependent release of [3H]GABA in cultured chick retina cells
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)